A Role for Ceramide, but Not Diacylglycerol, in the Antagonism of Insulin Signal Transduction by Saturated Fatty Acids
Open accessThe DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Abstract
Multiple studies suggest that lipid oversupply to skeletal muscle contributes to the development of insulin resistance, perhaps by promoting the accumulation of lipid metabolites capable of inhibiting signal transduction. Herein we demonstrate that exposing muscle cells to particular saturated free fatty acids (FFAs), but not mono-unsaturated FFAs, inhibits insulin stimulation of Akt/protein kinase B, a serine/threonine kinase that is a central mediator of insulin-stimulated anabolic metabolism. These saturated FFAs concomitantly induced the accumulation of ceramide and diacylglycerol, two products of fatty acyl-CoA that have been shown to accumulate in insulin-resistant tissues and to inhibit early steps in insulin signaling. Preventing de novo ceramide synthesis negated the antagonistic effect of saturated FFAs toward Akt/protein kinase B. Moreover, inducing ceramide buildup recapitulated and augmented the inhibitory effect of saturated FFAs. By contrast, diacylglycerol proved dispensable for these FFA effects. Collectively these results identify ceramide as a necessary and sufficient intermediate linking saturated fats to the inhibition of insulin signaling.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In particular, an overabundance of SFA (e.g., Palmitate) can induce IR through the accumulation of lipid derivatives including DAGs, ceramides and long chain acyl-CoAs in the cytosol, which in turn can interfere with IRS1-PKB signalling [113,114,115,116,117,118].”
From Omega-3 Fatty Acids and Skeletal Muscle Health (2015) · cites this paper as [118]
Experimental — accuracy not yet measuredIn the citing paper
“The deleterious effect of ceramide on insulin signalling results from its ability to block the activation of AKT via two independent mechanisms (Chavez and Summers, 2012). The first mechanism involves the phosphorylation of AKT on pleckstrin homology domain by PKCζ, which in turn is activated by ceramide. This lowers the affinity of AKT for phosphoinositide (Powell et al., 2003) and blocks AKT”
From Mitochondrial (Dys)function and Insulin Resistance: From Pathophysiological Molecular Mechanisms to the Impact of Diet (2019) · cites this paper as Chavez et al., 2003
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Randle, P. J., Garland, P. B., Hales, C. N., & Newsholme, E. A. (1963) · The Lancet · doi:10.1016/s0140-6736(63)91500-9 · Cited by 5,093
Cho, H., Mu, J., Kim, J. K., Thorvaldsen, J. L., Chu, Q., Crenshaw, E. B., Kaestner, K. H., Bartolomei, M. S., Shulman, G. I., & Birnbaum, M. J. (2001) · Science · doi:10.1126/science.292.5522.1728 · Cited by 1,836
Role of Fatty Acids in the Pathogenesis of Insulin Resistance and NIDDM
Boden, G. (1997) · Diabetes · doi:10.2337/diab.46.1.3 · Cited by 1,728
Yu, C., Chen, Y., Cline, G. W., Zhang, D., Zong, H., Wang, Y., Bergeron, R., Kim, J. K., Cushman, S. W., Cooney, G. J., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200958200 · Cited by 1,561
McGarry, J. D. (2002) · Diabetes · doi:10.2337/diabetes.51.1.7 · Cited by 1,435
Itani, S. I., Ruderman, N. B., Schmieder, F., & Boden, G. (2002) · Diabetes · doi:10.2337/diabetes.51.7.2005 · Cited by 1,390
Boden, G., & Shulman, G. I. (2002) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.32.s3.3.x · Cited by 1,300
Kohn, A. D., Summers, S. A., Birnbaum, M. J., & Roth, R. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.49.31372 · Cited by 1,284
Self-citationPhosphoinositide 3-kinase: the key switch mechanism in insulin signalling
SHEPHERD, P. R., WITHERS, D. J., & SIDDLE, K. (1998) · Biochemical Journal · doi:10.1042/bj3330471 · Cited by 953
Measurement of Plasma Glucose, Free Fatty Acid, Lactate, and Insulin for 24 h in Patients With NIDDM
Reaven, G. M., Hollenbeck, C., Jeng, C.-Y., Wu, M. S., & Chen, Y.-D. I. (1988) · Diabetes · doi:10.2337/diab.37.8.1020 · Cited by 753
Research works printed but not linked: 5
- Chen, 1991, Trans. Assoc. Am. Physicians, 104, 206
- Motley, 2001, Cell. Mol. Biol. (Noisy-le-Grand), 47, 1059
- Minamide, 2003, Methods Cell Biol.
- Yang, 1991, Mol. Cell. Biol., 11, 1988
- Chin, 1994, Mol. Endocrinol., 8, 51
Cited by
Items 101–200 of 627
Large-scale lipidomics identifies associations between plasma sphingolipids and T2DM incidence
Chew, W. S., Torta, F. T., Ji, S., Choi, H., Begum, H., Sim, X., Khoo, C. M., Khoo, E. Y. H., Ong, W., van Dam, R. M., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.126925 · Cited by 166
Roles of ceramide and sphingolipids in pancreatic β-cell function and dysfunction
Boslem, E., Meikle, P. J., & Biden, T. J. (2012) · Islets · doi:10.4161/isl.20102 · Cited by 173
Nonalcoholic fatty liver disease: A main driver of insulin resistance or a dangerous liaison?
Gruben, N., Shiri‐Sverdlov, R., Koonen, D. P. Y., & Hofker, M. H. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.08.004 · Cited by 167
“PKCs and PP2A have been shown to interfere with insulin signaling [49-52].”
BackgroundColl, T., Jové, M., Rodríguez-Calvo, R., Eyre, E., Palomer, X., Sánchez, R. M., Merlos, M., Laguna, J. C., & Vázquez-Carrera, M. (2006) · Diabetes · doi:10.2337/db05-1494 · Cited by 151
Ceramides and Glucosylceramides Are Independent Antagonists of Insulin Signaling
Chavez, J. A., Siddique, M. M., Wang, S. T., Ching, J., Shayman, J. A., & Summers, S. A. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.522847 · Cited by 147
“Palmitate-induced Insulin Resistance Is Unaffected by GCS Inhibition—The data showing roles for GSLs in rodent models of metabolic disease have relied on next generation GCS inhibitors that, unlike the compound used in our prior study (25), do not promote ceramide accumulation (19).”
Self-citationKey Role for Ceramides in Mediating Insulin Resistance in Human Muscle Cells
Pickersgill, L., Litherland, G. J., Greenberg, A. S., Walker, M., & Yeaman, S. J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611157200 · Cited by 146
Lipid Mediators of Insulin Resistance
Holland, W. L., Knotts, T. A., Chavez, J. A., Wang, L.-P., Hoehn, K. L., & Summers, S. A. (2008) · Nutrition Reviews · doi:10.1111/j.1753-4887.2007.tb00327.x · Cited by 139
Self-citationLennon, R., Pons, D., Sabin, M. A., Wei, C., Shield, J. P., Coward, R. J., Tavare, J. M., Mathieson, P. W., Saleem, M. A., & Welsh, G. I. (2009) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfp302 · Cited by 148
Lipids: An insight into the neurodegenerative disorders
Shamim, A., Mahmood, T., Ahsan, F., Kumar, A., & Bagga, P. (2018) · Clinical Nutrition Experimental · doi:10.1016/j.yclnex.2018.05.001 · Cited by 136
Lin, C.-F., Chen, C.-L., Chiang, C.-W., Jan, M.-S., Huang, W.-C., & Lin, Y.-S. (2007) · Journal of Cell Science · doi:10.1242/jcs.03473 · Cited by 140
“This is consistent with a previous report (Stoica et al., 2003), showing that the dephosphorylation of Akt and GSK3 is associated with ceramide-induced neuronal apoptosis.”
BackgroundPalmitoylethanolamide and other anandamide congeners. Proposed role in the diseased brain
Hansen, H. S. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2010.03.022 · Cited by 161
“OEA, known as N-oleoylethanolamine, has for many years been used as a recognized ceramidase inhibitor in numerous studies involving cell cultures (Chavez et al., 2003; Chmura et al., 2000; Furlong et al., 2008;Wiesner and Dawson, 1996).”
Fenretinide Prevents Lipid-induced Insulin Resistance by Blocking Ceramide Biosynthesis
Bikman, B. T., Guan, Y., Shui, G., Siddique, M. M., Holland, W. L., Kim, J. Y., Fabriàs, G., Wenk, M. R., & Summers, S. A. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.359950 · Cited by 131
“Protein Analysis—Tissue extracts were resolved by SDSPAGE, transferred to nitrocellulose, and immunoblotted using methods described previously (20).”
MethodSelf-citationSphingolipids and insulin resistance: the five Ws
Summers, S. A. (2010) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3283373b66 · Cited by 136
Self-citationSaravanan, N., Haseeb, A., Ehtesham, N. Z., & Ghafoorunissa (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.01946 · Cited by 136
“It is well established that SFAs induce insulin resistance through the ceramide-dependent pathway ( 45 ).”
BackgroundUssher, J. R., Koves, T. R., Jaswal, J. S., Zhang, L., Ilkayeva, O., Dyck, J. R. B., Muoio, D. M., & Lopaschuk, G. D. (2009) · Diabetes · doi:10.2337/db09-0011 · Cited by 135
“The lack of alteration in myocardial ceramide content may be related to the dynamic nature of this sphingolipid pool, the size of which is determined by its rates of both synthesis and degradation (35).”
BackgroundMullen, K. L., Pritchard, J., Ritchie, I., Snook, L. A., Chabowski, A., Bonen, A., Wright, D., & Dyck, D. J. (2009) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.90774.2008 · Cited by 132
Bosma, M., Kersten, S., Hesselink, M. K. C., & Schrauwen, P. (2011) · Progress in Lipid Research · doi:10.1016/j.plipres.2011.11.003 · Cited by 156
“Indeed, ceramide was identified as an essential intermediate linking saturated FAs to insulin resistance [62].”
BackgroundPathophysiology of type 2 diabetes and the impact of altered metabolic interorgan crosstalk
Sanches, J. M., Zhao, L. N., Salehi, A. A., Wollheim, C. B., & Kaldis, P. (2021) · FEBS Journal · doi:10.1111/febs.16306 · Cited by 151
Jové, M., Planavila, A., Laguna, J. C., & Vázquez-Carrera, M. (2005) · Endocrinology · doi:10.1210/en.2004-1560 · Cited by 133
“Because palmitate impairs serine/threonine protein kinase Akt phosphorylation (14), it is tempting to speculate that IL-6 may mediate changes in the phosphorylation of the Akt, which promotes translocation of glucose transporter GLUT4 to the plasma membrane.”
BackgroundAltered Skeletal Muscle Lipase Expression and Activity Contribute to Insulin Resistance in Humans
Badin, P.-M., Louche, K., Mairal, A., Liebisch, G., Schmitz, G., Rustan, A. C., Smith, S. R., Langin, D., & Moro, C. (2011) · Diabetes · doi:10.2337/db10-1364 · Cited by 132
“Lean (9) Obese (9) Type 2 diabetes (8)”
Impaired mitochondrial fat oxidation induces adaptive remodeling of muscle metabolism
Wicks, S. E., Vandanmagsar, B., Haynie, K. R., Fuller, S. E., Warfel, J. D., Stephens, J. M., Wang, M., Han, X., Zhang, J., Noland, R. C., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1418560112 · Cited by 131
“Proc Natl Acad Sci USA 110(5):1869–1874.”
InfluentialLongato, L., Ripp, K., Setshedi, M., Dostalek, M., Akhlaghi, F., Branda, M., Wands, J. R., & de la Monte, S. M. (2012) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2012/479348 · Cited by 133
“However, we focused our studies on the potential contributions of ceramides in chronic ALD because (1) ceramides have demonstrated roles in the pathogenesis of steatohepatitis in experimental models of chronic ethanol or high-fat diet feeding [10, 11]; (2) ceramides can promote insulin resistance, inflammation, and ox…”
BackgroundLipidomics as a Principal Tool for Advancing Biomedical Research
Lam, S. M., & Shui, G. (2013) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2013.06.007 · Cited by 139
Gosejacob, D., Jäger, P. S., Dorp, K. V., Frejno, M., Carstensen, A., Köhnke, M., Degen, J., Dörmann, P., & Hoch, M. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.691212 · Cited by 142
Ceramides and mitochondrial fatty acid oxidation in obesity
Fucho, R., Casals, N., Serra, D., & Herrero, L. (2016) · The FASEB Journal · doi:10.1096/fj.201601156r · Cited by 136
Rimbert, V., Boirie, Y., Bedu, M., Hocquette, J., Ritz, P., & Morio, B. (2004) · The FASEB Journal · doi:10.1096/fj.03-1104fje · Cited by 123
“, diacylglycerol and ceramide) that are likely to disrupt early steps in insulin signal transduction (8, 41).”
BackgroundContribution of FAT/CD36 to the regulation of skeletal muscle fatty acid oxidation: an overview
Holloway, G. P., Luiken, J. J. F. P., Glatz, J. F. C., Spriet, L. L., & Bonen, A. (2008) · Acta Physiologica · doi:10.1111/j.1748-1716.2008.01878.x · Cited by 120
“…(IRS-1) (Boneh 1995, Idris et al. 2001), while ceramides both diminish the phosphorylation of Akt/PKB by activating a protein phosphatase (Teruel et al. 2001, Chavez et al. 2003) and inhibit the translocation of Akt/PKB to the plasma membrane, the site of phosphorylation (Powell et al. 2003, 2004).”
BackgroundGlycosphingolipids and insulin resistance
Langeveld, M., & Aerts, J. M. F. G. (2009) · Progress in Lipid Research · doi:10.1016/j.plipres.2009.03.002 · Cited by 132
“Exposing cultured myotubes to high doses of the free fatty acid (FFA) palmitate increases de novo ceramide synthesis, followed by inhibition of PKB phosphorylation 14,83,84 , glucose uptake 85 and glycogen synthesis 86 .”
Hyde, R., Hajduch, E., Powell, D. J., Taylor, P. M., & Hundal, H. S. (2005) · The FASEB Journal · doi:10.1096/fj.04-2284fje · Cited by 126
Radin, M. S., Sinha, S., Bhatt, B. A., Dedousis, N. L., & O'Doherty, R. M. (2007) · Diabetologia · doi:10.1007/s00125-007-0861-3 · Cited by 133
“In previous studies [13] we demonstrated that the acute (6 h) exposure of L6 myotubes to palmitate induces insulin resistance, in agreement with numerous studies that have demonstrated the induction of insulin resistance in vitro and in vivo in response to a period of acute hyperlipidaemia [11, 13, 31, 39–41].”
BackgroundResultSu, K., Yi, B., Yao, B.-Q., Xia, T., Yang, Y., Zhang, Z., & Chen, C. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104778 · Cited by 126
Fatty acids stimulate AMP‐activated protein kinase and enhance fatty acid oxidation in L6 myotubes
Watt, M. J., Steinberg, G. R., Chen, Z., Kemp, B. E., & Febbraio, M. A. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.107318 · Cited by 120
“Because palmitate treatment can result in the cellular accumulation of bioactive lipid species such as ceramide (Chavez et al. 2003), cells were also incubated in the presence of the polyunsaturated fatty acid linoleate.”
BackgroundMolecular mechanism of insulin resistance
Bhattacharya, S., Dey, D., & Roy, S. S. (2007) · Journal of Biosciences · doi:10.1007/s12038-007-0038-8 · Cited by 143
Strle, K., Broussard, S. R., McCusker, R. H., Shen, W.-H., Johnson, R. W., Freund, G. G., Dantzer, R., & Kelley, K. W. (2004) · Endocrinology · doi:10.1210/en.2003-1749 · Cited by 115
“Recently, cell-permeable ceramide analogs have been implicated in blocking insulininduced AKT activity (30, 46) and PDGF-induced thymidine incorporation in muscle cells (47).”
BackgroundSelective Insulin Resistance in Adipocytes
Tan, S.-X., Fisher-Wellman, K. H., Fazakerley, D. J., Ng, Y., Pant, H., Li, J., Meoli, C. C., Coster, A. C. F., Stöckli, J., & James, D. E. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.623686 · Cited by 112
“Although the mechanism(s) that contribute to insulin resistance remain controversial, defects within the insulin signaling network, either upstream (insulin receptor, insulin receptor substrate 1) (9 –11), downstream (AS160) (6), or at Akt itself (12, 13) have been identified as potential targets.”
BackgroundWei, W., An, X.-R., Jin, S.-J., Li, X.-X., & Xu, M. (2018) · Scientific Reports · doi:10.1038/s41598-017-18427-2 · Cited by 117
Longato, L., Tong, M., Wands, J. R., & de la Monte, S. M. (2012) · Hepatology Research · doi:10.1111/j.1872-034x.2011.00934.x · Cited by 116
Ibrahim, A., Natarajan, S., & Ghafoorunissa (2005) · Metabolism · doi:10.1016/j.metabol.2004.08.019 · Cited by 114
Carnitine revisited: potential use as adjunctive treatment in diabetes
Power, R. A., Hulver, M. W., Zhang, J. Y., Dubois, J., Marchand, R. M., Ilkayeva, O., Muoio, D. M., & Mynatt, R. L. (2007) · Diabetologia · doi:10.1007/s00125-007-0605-4 · Cited by 113
“Ceramides activate a protein phosphatase that dephosphorylates AKT/protein kinase B, resulting in inhibition of GLUT4 translocation and glycogen synthesis [33, 34].”
Sphingolipid signalling in the cardiovascular system: Good, bad or both?
Alewijnse, A. E., & Peters, S. L. M. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.02.089 · Cited by 113
Non-alcoholic fatty liver disease and insulin resistance: From bench to bedside
Gariani, K., Philippe, J., & Jornayvaz, F. R. (2013) · Diabetes & Metabolism · doi:10.1016/j.diabet.2012.11.002 · Cited by 113
“[74] Chavez JA, Knotts TA, Wang LP, Li G, Dobrowsky RT, Florant GL, et al.”
BackgroundSphingolipids as a Culprit of Mitochondrial Dysfunction in Insulin Resistance and Type 2 Diabetes
Roszczyc-Owsiejczuk, K., & Zabielski, P. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.635175 · Cited by 123
Sphingolipids in Obesity, Type 2 Diabetes, and Metabolic Disease
Russo, S. B., Ross, J. S., & Cowart, L. A. (2013) · Handbook of experimental pharmacology · doi:10.1007/978-3-7091-1511-4_19 · Cited by 126
“And, moreover, inhibitors of sphingolipid biosynthesis protect cells from the insulin-desensitizing effects of palmitate (Chavez et al. 2003)..”
BackgroundInfluentialRole of ceramides in the pathogenesis of diabetes mellitus and its complications
Mandal, N. A., Grambergs, R. C., Mondal, K., Basu, S. K., Tahia, F., & Dagogo-Jack, S. E. (2020) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2020.107734 · Cited by 117
Differential Utilization of Saturated Palmitate and Unsaturated Oleate
Gaster, M., Rustan, A. C., & Beck-Nielsen, H. (2005) · Diabetes · doi:10.2337/diabetes.54.3.648 · Cited by 106
“Ceramide is a palmitate derivative and a second messenger produced by sphingomyelinase activation, and it is known to be increased in insulin-resistant cell systems (40,49).”
BackgroundChen, L., Ren, J., Yang, L., Li, Y., Fu, J. X., Li, Y., Tian, Y., Qiu, F., Liu, Z., & Qiu, Y. (2016) · Scientific Reports · doi:10.1038/srep19665 · Cited by 120
Ceramides as Mediators of Oxidative Stress and Inflammation in Cardiometabolic Disease
Gaggini, M., Ndreu, R., Michelucci, E., Rocchiccioli, S., & Vassalle, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052719 · Cited by 115
SMPDL3b modulates insulin receptor signaling in diabetic kidney disease
Mitrofanova, A. V., Mallela, S. K., Ducasa, G. M., Yoo, T., Rosenfeld-Gur, E., Zelnik, I. D., Molina, J., Santos, J. V., Ge, M., Sloan, A. J., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10584-4 · Cited by 118
Gender-Related Differences in the Metabolic Response to Fasting
Soeters, M. R., Sauerwein, H. P., Groener, J. E., Aerts, J. M., Ackermans, M. T., Glatz, J. F. C., Fliers, E., & Serlie, M. J. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0552 · Cited by 103
Role of Sphingolipid Mediator Ceramide in Obesity and Renal Injury in Mice Fed a High-Fat Diet
Boini, K. M., Zhang, C., Xia, M., Poklis, J. L., & Li, P. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.168815 · Cited by 109
“Inhibiting de novo ceramide synthesis prevented palmitate-mediated ceramide accumulation and inhibition of insulin signaling (Chavez et al., 2003; Powell et al., 2004; Summers, 2006).”
BackgroundTalati, M. H., & Hemnes, A. R. (2015) · Pulmonary Circulation · doi:10.1086/681227 · Cited by 112
“which inhibits insulin stimulation of Akt/protein kinase B, a serine/ threonine kinase.(106) In the cardiomyocyte cell line AC16, C6-”
BackgroundLee, J.-Y., Cho, H.-K., & Kwon, Y. H. (2009) · Metabolism · doi:10.1016/j.metabol.2009.10.012 · Cited by 115
“The inhibition of ceramide synthesis ameliorates obesity-induced insulin resistance in skeletal muscles and liver [52] and myoblasts [53] without changes in intracellular level of DAG.”
BackgroundCeylan‐Isik, A. F., Kandadi, M. R., Xu, X., Hua, Y., Chicco, A. J., Ren, J. T., & Nair, S. (2013) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2013.07.002 · Cited by 105
Sphingolipids: players in the pathology of metabolic disease
Cowart, L. A. (2008) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2008.09.004 · Cited by 105
Hatoum, D., Haddadi, N., Lin, Y., Nassif, N. T., & McGowan, E. M. (2017) · Oncotarget · doi:10.18632/oncotarget.16370 · Cited by 105
Guria, S., Hoory, A., Das, S., Chattopadhyay, D., & Mukherjee, S. (2023) · Bioscience Reports · doi:10.1042/bsr20220200 · Cited by 118
Kashyap, S. R., Belfort, R., Berria, R., Suraamornkul, S., Pratipranawatr, T., Finlayson, J., Barrentine, A., Bajaj, M., Mandarino, L., DeFronzo, R., et al. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00541.2003 · Cited by 103
Cavaliere, G., Cimmino, F., Trinchese, G., Catapano, A., Petrella, L., D’Angelo, M., Lucchin, L., & Mollica, M. P. (2023) · Antioxidants · doi:10.3390/antiox12061172 · Cited by 118
“The role of CERs in the liver has been less studied, but it is also emerging as a potentially important pathway for hepatic insulin resistance development, probably due to the inhibition of Akt/PKB (protein kinase B), a key element in the insulin signaling pathway [79].”
Backgroundde la Monte, S. M. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-111727 · Cited by 109
Ceramide-Mediated Insulin Resistance and Impairment of Cognitive-Motor Functions
de la Monte, S. M., Tong, M., Nguyen, V., Setshedi, M., Longato, L., & Wands, J. R. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-091726 · Cited by 114
“These findings are consistent with previous reports demonstrating that ceramides impair insulin signaling throughthe Akt pathway [14,15,39,93],and also with our previous findings that bioactive synthetic ce-ramides (C2Cer or C6Cer) impair insulin/IGF signaling through inhibition of receptor and IRS…”
InfluentialBrindley, D. N., Kok, B. P., Kienesberger, P. C., Lehner, R. S., & Dyck, J. R. B. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00509.2009 · Cited by 108
“1), which can cause apoptosis of cardiomyocytes (117) and insulin resistance in cells (25, 163).”
BackgroundØrtenblad, N., Mogensen, M., Petersen, I., Højlund, K., Levin, K., Sahlin, K., Beck-Nielsen, H., & Gaster, M. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2005.04.001 · Cited by 101
CD36 inhibition prevents lipid accumulation and contractile dysfunction in rat cardiomyocytes
Angin, Y., Steinbusch, L. K. M., Simons, P. J., Greulich, S., Hoebers, N. T. H., Douma, K., van Zandvoort, M. A. M. J., Coumans, W. A., Wijnen, W., Diamant, M., et al. (2012) · Biochemical Journal · doi:10.1042/bj20120060 · Cited by 99
Sun, L., Yang, Z., Zhao, W., Chen, Q., Bai, H.-Y., Wang, S., Li, Y., Bi, C., Shi, Y., & Liu, Y. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114699 · Cited by 100
Pinnamaneni, S. K., Southgate, R. J., Febbraio, M. A., & Watt, M. J. (2006) · Diabetologia · doi:10.1007/s00125-006-0427-9 · Cited by 106
“Second, incubating cells with saturated fatty acids leads to insulin resistance, subsequent to increases in ceramide and DAG content [11–13].”
BackgroundPhysical inactivity, insulin resistance, and the oxidative-inflammatory loop
Gratas-Delamarche, A., Derbré, F., Vincent, S., & Cillard, J. (2014) · Free Radical Research · doi:10.3109/10715762.2013.847528 · Cited by 99
Targeting ceramide metabolism in obesity
Aburasayn, H., Al Batran, R., & Ussher, J. R. (2016) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00133.2016 · Cited by 96
“Subsequent studies indicated that an increase in cellular ceramide content disturbs cellular glucose metabolism primarily through the inhibition of Akt [also known as protein kinase B (PKB)] (45, 105), a serine/threonine kinase that is essential for insulin signaling and insulin-mediated stimulation of glucose metabol…”
BackgroundInfluentialSphingolipid Content of Human Adipose Tissue: Relationship to Adiponectin and Insulin Resistance
Blachnio‐Zabielska, A. U., Koutsari, C., Tchkonia, T., & Jensen, M. D. (2012) · Obesity · doi:10.1038/oby.2012.126 · Cited by 96
The molecular mechanism linking muscle fat accumulation to insulin resistance
Hulver, M. W., & Lynis Dohm, G. (2004) · Proceedings of the Nutrition Society · doi:10.1079/pns2004351 · Cited by 98
“Ceramides activate a protein phosphatase that dephosphorylates akt/protein kinase B resulting in inhibition of GLUT4 translocation and glycogen synthesis (Long & Pekala, 1996; Chavez et al. 2003).”
BackgroundNovel Insights and Mechanisms of Lipotoxicity-Driven Insulin Resistance
Lair, B., Laurens, C., Bosch, B. V. D., & Moro, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176358 · Cited by 106
Ceramide metabolism is affected by obesity and diabetes in human adipose tissue
Błachnio-Zabielska, A. U., Pulka, M., Baranowski, M., Nikołajuk, A., Zabielski, P., Górska, M., & Górski, J. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22745 · Cited by 97
“Recent research has provided information on the role of ceramide (Cer) in induction of insulin resistance, not only in skeletalmuscle cells (Hajduch et al., 2001; Chavez and Summers, 2003; Chavez et al., 2003) but also in the adipocytes (Long and Pekala, 1996).”
BackgroundDeclèves, A., & Sharma, K. (2014) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000087 · Cited by 116
“This adverse effect was associated with an increase of ceramide, a highly lipotoxic molecule, that has been reported to play a role in insulin resistance [43].”
BackgroundPeck, G. R., Chavez, J. A., Roach, W. G., Budnik, B. A., Lane, W. S., Karlsson, H. K. R., Zierath, J. R., & Lienhard, G. E. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.035568 · Cited by 95
Self-citationBenton, C. R., Wright, D. C., & Bonen, A. (2008) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/h08-074 · Cited by 91
On ceramides, other sphingolipids and impaired glucose homeostasis
Larsen, P. J., & Tennagels, N. (2014) · Molecular Metabolism · doi:10.1016/j.molmet.2014.01.011 · Cited by 93
“Dephosphorylation of Thr(308) and/or Ser(473) in PKB/ Akt leaves it inactivated whereby translocation to the plasma membrane does not occur [36].”
BackgroundOh, D. Y., & Lagakos, W. (2011) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e3283479230 · Cited by 100
Palmitate-induced Down-regulation of Sortilin and Impaired GLUT4 Trafficking in C2C12 Myotubes
Tsuchiya, Y., Hatakeyama, H., Emoto, N., Wagatsuma, F., Matsushita, S., & Kanzaki, M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.128520 · Cited by 90
Glucocorticoid-induced apoptosis and cellular mechanisms of myopathy
Dirks‐Naylor, A. J., & Griffiths, C. L. (2009) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2009.05.014 · Cited by 99
Gilbert, M. (2021) · Journal of Diabetes Investigation · doi:10.1111/jdi.13614 · Cited by 97
Hu, W., Ross, J., Geng, T., Brice, S. E., & Cowart, L. A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.186916 · Cited by 86
Castorena, C. M., Arias, E. B., Sharma, N., & Cartee, G. D. (2014) · Diabetes · doi:10.2337/db13-1686 · Cited by 87
“Earlier research linked DAG-associated insulin resistance to JNK activation and greater serine phosphorylation of IRS-1 (47,48) and demonstrated that ceramides can promote Akt dephosphorylation (49,50).”
BackgroundSadeghi, A., Seyyed Ebrahimi, S. S., Golestani, A., & Meshkani, R. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25868 · Cited by 87
“BSA conjugated palmitate was prepared as previously reported [Chavez et al., 2003].”
MethodSphingolipid metabolism in non-alcoholic fatty liver diseases
Régnier, M., Polizzi, A., Guillou, H., & Loiseau, N. (2018) · Biochimie · doi:10.1016/j.biochi.2018.07.021 · Cited by 94
Ubiquitin Ligases at the Heart of Skeletal Muscle Atrophy Control
Peris-Moreno, D., Cussonneau, L., Combaret, L., Polge, C., & Taillandier, D. (2021) · Molecules · doi:10.3390/molecules26020407 · Cited by 95
“Ceramide, is linked to muscle atrophy through (i) the reduction of protein synthesis [145–148] and (ii) the activation of NF-κ B [149–151].”
Alkhateeb, H., Chabowski, A., Glatz, J. F. C., Luiken, J. F. P., & Bonen, A. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00685.2006 · Cited by 87
“It is thought that ceramides, derived from saturated fatty acids, interfere with insulin action by reducing Akt phosphorylation/activation and translocation (14, 15, 24, 28, 51, 52, 56).”
BackgroundCathepsin K Knockout Mitigates High-Fat Diet–Induced Cardiac Hypertrophy and Contractile Dysfunction
Hua, Y., Zhang, Y., Dolence, J. M., Shi, G., Ren, J. T., & Nair, S. (2012) · Diabetes · doi:10.2337/db12-0350 · Cited by 88
“Palmitate-containing media was prepared by conjugating palmitic acid with fatty acid–free bovine serum albumin (28).”
MethodHu, W., Bielawski, J., Samad, F., Merrill, A. H., & Cowart, L. A. (2009) · Journal of Lipid Research · doi:10.1194/jlr.m800635-jlr200 · Cited by 87
Capel, F., Acquaviva, C., Pitois, E., Laillet, B., Rigaudière, J.-P., Jouve, C., Pouyet, C., Gladine, C., Comte, B., Vianey Saban, C., et al. (2015) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2015.04.003 · Cited by 86
“These results confirmed the contribution of ceramide accumulation to the inhibition of insulindependent Akt activation [5].”
BackgroundRole of hormone-sensitive lipase in β-adrenergic remodeling of white adipose tissue
Mottillo, E. P., Shen, X. J., & Granneman, J. G. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00051.2007 · Cited by 84
“1 and 2) and products of FFA metabolism (3, 16) can serve as intra- and extracellular signaling molecules.”
Mielke, M. M., Bandaru, V. V. R., Han, D., An, Y., Resnick, S. M., Ferrucci, L., & Haughey, N. J. (2015) · Aging Cell · doi:10.1111/acel.12369 · Cited by 91
“, 2001), and promotes the dephosphorylation of Akt/PKB by protein phosphatase 2A (Chavez et al., 2003).”
BackgroundReappraisal of Adipose Tissue Inflammation in Obesity
Engin, A. (2024) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-63657-8_10 · Cited by 97
Hassan, R. H., Hainault, I., Vilquin, J., Samama, C. M., Lasnier, F., Ferré, P., Foufelle, F., & Hajduch, É. (2011) · Diabetologia · doi:10.1007/s00125-011-2328-9 · Cited by 94
“The modest activation of this pathway by palmitate (or directly with ceramides) explains why, in contrast with tunicamycin, palmitate and ceramides have no negative impact on IRS-1 in muscle cells and act only at the level of PKB/Akt, as described previously [8, 10, 12].”
BackgroundDubé, J. J., Coen, P. M., DiStefano, G., Chacon, A. C., Helbling, N. L., Desimone, M. E., Stafanovic-Racic, M., Hames, K. C., Despines, A. A., Toledo, F. G. S., et al. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00257.2014 · Cited by 83
“, diacylglycerol, ceramide) accumulation (8, 26, 37, 50), which is known to mediate insulin signaling.”
BackgroundSphingolipids: agents provocateurs in the pathogenesis of insulin resistance
Lipina, C., & Hundal, H. S. (2011) · Diabetologia · doi:10.1007/s00125-011-2127-3 · Cited by 83
“As expected, these beneficial effects of myriocin are associated with reduced levels of circulating ceramide and are reproduced when alternative inhibitors of de novo ceramide synthesis such as L-cycloserine (which also inhibits SPT) and fumonisin B1 (dihydroceramide synthase inhibitor) are used [15, 16, 35].”
BackgroundInfluentialBekhite, M. M., Delgado, A. G., Hübner, S., Haxhikadrija, P., Kretzschmar, T., Müller, T., Wu, J. M. F., Bekfani, T., Franz, M., Wartenberg, M., et al. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.02.016 · Cited by 91
Fazakerley, D. J., van Gerwen, J., Cooke, K. C., Duan, X., Needham, E. J., Díaz‐Vegas, A., Madsen, S., Norris, D. M., Shun-Shion, A. S., Krycer, J. R., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-36549-2 · Cited by 88
High fat diet induces ceramide and sphingomyelin formation in rat’s liver nuclei
Chocian, G., Chabowski, A., Żendzian‐Piotrowska, M., Harasim‐Symbor, E., Łukaszuk, B., & Górski, J. (2010) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-010-0409-6 · Cited by 83
“Our HFD was enriched in saturated FAs and we may speculate that increased availability of saturated FA leads to enhanced accumulation of these FA species in ceramide and sphingomyelin, since saturated FAs are less readily oxidized [32–34].”
BackgroundRudich, A., Ben-Romano, R., Etzion, S., & Bashan, N. (2005) · Acta Physiologica Scandinavica · doi:10.1111/j.1365-201x.2004.01383.x · Cited by 90
Siddique, M. M., Li, Y., Wang, L., Ching, J., Mal, M., Ilkayeva, O., Wu, Y., Bay, B., & Summers, S. A. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00226-13 · Cited by 90
“Both exogenous and endogenous ceramides inhibit Akt phosphorylation and activation without blocking any upstream signaling events (26, 55).”
BackgroundSelf-citationInvited review: Sphingolipid biology in the dairy cow: The emerging role of ceramide
McFadden, J. W., & Rico, J. E. (2019) · Journal of Dairy Science · doi:10.3168/jds.2018-16095 · Cited by 87
Metadata
- Authors
- Chavez, J. A., Knotts, T. A., Wang, L.-P., Li, G., Dobrowsky, R. T., Florant, G. L., & Summers, S. A.
- Affiliations
- Colorado State University (US)
- University of Kansas (US)
- Corresponding author
- Summers, Scott A.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2003-03
- Volume
- 278
- Issue
- 12
- Pages
- 10297-10303
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1984413737
- Cited by
- 617
- References
- 67
- Citations by year
- 2026: 11 · 2025: 11 · 2024: 19 · 2023: 15 · 2022: 18 · 2021: 36 · 2020: 30 · 2019: 25 · 2018: 27 · 2017: 38 · 2016: 32 · 2015: 31 · 2014: 29 · 2013: 33 · 2012: 44
- FWCI
- 6.86
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6424 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- American Diabetes Association
- March of Dimes Foundation
- American Heart Association
- Colorado State University
- National Institutes of Health (5r21dk059749-02, 5r21dk060676-02)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK59749, R21-DK60676, R01DK058784)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sphingolipid Metabolism and Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Keywords
- ceramide, diacylglycerol, saturated fatty acids, insulin resistance, insulin signaling, Akt/protein kinase B, skeletal muscle, de novo ceramide synthesis, monounsaturated fatty acids
- MeSH terms
- Glycogen Synthase Kinase 3 beta, Animals, Cells, Cultured, Ceramides, Diglycerides, Fatty Acids, Fatty Acids, Nonesterified, Insulin, Phosphorylation, Proto-Oncogene Proteins, Signal Transduction, Protein Serine-Threonine Kinases, Muscle, Skeletal, Glycogen Synthase Kinase 3, Proto-Oncogene Proteins c-akt, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.